Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lexaria Bioscience Corp (NQ: LEXX ) 2.970 +0.040 (+1.37%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 171,420 Open 2.920 Bid (Size) 3.080 (5) Ask (Size) 3.240 (2) Prev. Close 2.930 Today's Range 2.890 - 3.100 52wk Range 0.7000 - 6.850 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Engages CRO for DehydraTECH GLP-1 Human Study June 18, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study June 18, 2024 Via ACCESSWIRE Performance YTD +130.23% +130.23% 1 Month +1.71% +1.71% 3 Month -25.75% -25.75% 6 Month +111.39% +111.39% 1 Year +306.29% +306.29% More News Read More Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO; Set for First Tirzepatide Molecule Study June 17, 2024 Via Investor Brand Network 7 A-Rated Biotech Stocks Worth Betting on in June June 14, 2024 Via InvestorPlace Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Patent Portfolio to 43 Granted Patents Worldwide June 06, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study June 05, 2024 Via ACCESSWIRE Lexaria Awards Contract For Third GLP-1 Human Pilot Study May 23, 2024 Via ACCESSWIRE CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study June 05, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study June 05, 2024 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property Product Safety Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 04, 2024 Via InvestorPlace Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 30, 2024 Via Benzinga 7 A-Rated Penny Stocks Work Betting On in H2 2024 May 30, 2024 Via InvestorPlace Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024 May 28, 2024 Via CannabisNewsWire Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024 May 28, 2024 Via Investor Brand Network CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study May 23, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study May 23, 2024 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Granted Two New US Patents in Hypertension, Epilepsy May 22, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy May 21, 2024 Via ACCESSWIRE CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of Dosing in Comprehensive GLP-1 Animal Study May 17, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study May 17, 2024 Via ACCESSWIRE TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets May 16, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation May 14, 2024 Via Investor Brand Network Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation May 14, 2024 Via CannabisNewsWire Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Extend Operational Runway to 2025 Following Warrant Exercise and Issuance May 09, 2024 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.